Literature DB >> 6106360

Kinetic studies of mefloquine and of one of its metabolites, Ro 21-5104, in the dog and in man.

D E Schwartz, W Weber, D Richard-Lenoble, M Gentilini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6106360

Source DB:  PubMed          Journal:  Acta Trop        ISSN： 0001-706X            Impact factor:   3.112


× No keyword cloud information.
  14 in total

1.  Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.

Authors:  F D Juma; J O Ogeto
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

2.  Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.

Authors:  S M Mansor; V Navaratnam; M Mohamad; S Hussein; A Kumar; A Jamaludin; W H Wernsdorfer
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  Carboxymefloquine, the major metabolite of the antimalarial drug mefloquine, induces drug-metabolizing enzyme and transporter expression by activation of pregnane X receptor.

Authors:  Rita Piedade; Stefanie Traub; Andreas Bitter; Andreas K Nüssler; José P Gil; Matthias Schwab; Oliver Burk
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

4.  Development of recommendations for the protection of short-stay travellers to malaria endemic areas: Memorandum from two WHO Meetings.

Authors: 
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

5.  Effectiveness of mefloquine against Clonorchis sinensis in rats and Paragonimus westermani in dogs.

Authors:  Shu-hua Xiao; Jian Xue; Xu Li-li; Yong-nian Zhang; Hui-qing Qiang
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

Review 6.  Clinical pharmacokinetics of mefloquine.

Authors:  J Karbwang; N J White
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 8.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

9.  Relaxant effects of mefloquine on vascular smooth muscle in vitro.

Authors:  B J Adegunloye; O A Sofola; H A Coker
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers.

Authors:  S Looareesuwan; N J White; D A Warrell; I Forgo; U G Dubach; U B Ranalder; D E Schwartz
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.